Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): C-$0.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.47. In 2024 the company made an earnings per share (EPS) of C$1.61 a decrease over its 2023 EPS that were of C$4.90.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.67-141.55%
2024C$1.61-67.16%
2023C$4.90-199.64%
2022C-$4.9299.03%
2021C-$2.47-68.98%
2020C-$7.97-298.06%
2019C$4.02-554.64%
2018C-$0.89-77.18%
2017C-$3.88-326.21%
2016C$1.71-134.19%
2015C-$5.01-371.34%
2014C$1.85-445.98%
2013C-$0.5332.88%
2012C-$0.40-82.07%
2011C-$2.24-817.9%
2010C$0.3112.73%
2009C$0.28-120.79%
2008C-$1.33-37.67%
2007C-$2.1439.64%
2006C-$1.5328.17%
2005C-$1.196.25%
2004C-$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
C$4.19-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$14.42-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.12-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$1.87-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C-$2.03 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.13-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.87-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$4.97-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$10.49-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA